메뉴 건너뛰기




Volumn 318, Issue 5852, 2007, Pages 930-936

A general model of prion strains and their pathogenicity

Author keywords

[No Author keywords available]

Indexed keywords

MAMMAL; MOLECULAR ANALYSIS; NUCLEIC ACID; PATHOGENICITY; PRION DISEASE; PROTEIN; TOXIC SUBSTANCE; YEAST;

EID: 36049020231     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1138718     Document Type: Review
Times cited : (900)

References (87)
  • 4
    • 0242684410 scopus 로고    scopus 로고
    • S. Mead et al., Science 300, 640 (2003).
    • (2003) Science , vol.300 , pp. 640
    • Mead, S.1
  • 6
    • 0030820354 scopus 로고    scopus 로고
    • A. F. Hill et al., Nature 389, 448 (1997).
    • (1997) Nature , vol.389 , pp. 448
    • Hill, A.F.1
  • 7
    • 0030775632 scopus 로고    scopus 로고
    • M. E. Bruce et al., Nature 389, 498 (1997).
    • (1997) Nature , vol.389 , pp. 498
    • Bruce, M.E.1
  • 8
  • 9
    • 33745440706 scopus 로고    scopus 로고
    • J. Collinge et al., Lancet 367, 2068 (2006).
    • (2006) Lancet , vol.367 , pp. 2068
    • Collinge, J.1
  • 10
    • 33845227845 scopus 로고    scopus 로고
    • S. J. Wroe et al., Lancet 368, 2061 (2006).
    • (2006) Lancet , vol.368 , pp. 2061
    • Wroe, S.J.1
  • 14
    • 3442889359 scopus 로고    scopus 로고
    • G. Legname et al., Science 305, 673 (2004).
    • (2004) Science , vol.305 , pp. 673
    • Legname, G.1
  • 15
    • 0001074386 scopus 로고
    • C. J. Gajdusek, C. J. Gibbs, M. P. Alpers, Eds, U.S. Government Printing Office, Washington, DC
    • I. H. Pattison, in Slow, Latent and Temperate Virus Infections, NINDB Monograph 2, C. J. Gajdusek, C. J. Gibbs, M. P. Alpers, Eds. (U.S. Government Printing Office, Washington, DC, 1965), pp. 249-257.
    • (1965) Slow, Latent and Temperate Virus Infections, NINDB Monograph , vol.2 , pp. 249-257
    • Pattison, I.H.1
  • 16
    • 0025244011 scopus 로고
    • S. B. Prusiner et al., Cell 63, 673 (1990).
    • (1990) Cell , vol.63 , pp. 673
    • Prusiner, S.B.1
  • 20
    • 13344293718 scopus 로고
    • J. Collinge et al., Nature 378, 779 (1995).
    • (1995) Nature , vol.378 , pp. 779
    • Collinge, J.1
  • 25
    • 12644272790 scopus 로고    scopus 로고
    • G. C. Telling et al., Science 274, 2079 (1996).
    • (1996) Science , vol.274 , pp. 2079
    • Telling, G.C.1
  • 26
    • 0031720905 scopus 로고    scopus 로고
    • J. Safar et al., Nat. Med. 4, 1157 (1998).
    • (1998) Nat. Med , vol.4 , pp. 1157
    • Safar, J.1
  • 30
    • 0027956109 scopus 로고
    • D. A. Kocisko et al., Nature 370, 471 (1994).
    • (1994) Nature , vol.370 , pp. 471
    • Kocisko, D.A.1
  • 31
    • 0028997297 scopus 로고
    • R. A. Bessen et al., Nature 375, 698 (1995).
    • (1995) Nature , vol.375 , pp. 698
    • Bessen, R.A.1
  • 34
    • 0028052363 scopus 로고
    • D. Westaway et al., Cell 76, 117 (1994).
    • (1994) Cell , vol.76 , pp. 117
    • Westaway, D.1
  • 35
    • 84888732359 scopus 로고    scopus 로고
    • Our unpublished data with aged tga20 mice
    • Our unpublished data with aged tga20 mice.
  • 37
    • 22744448690 scopus 로고    scopus 로고
    • K. E. Nazor et al., EMBO J. 24, 2472 (2005).
    • (2005) EMBO J , vol.24 , pp. 2472
    • Nazor, K.E.1
  • 38
    • 84888650990 scopus 로고    scopus 로고
    • In these experiments, 30 μl of PrP (0.5 mg/ml) was inoculated, which equates to >1014 molecules. An infectious unit of bona fide prion material approximates to 104 to 105 PrP molecules. Therefore, if composed primarily of infectious material, such a synthetic prion inoculum would contain 109 to 1010 infectious units. If dilution of the synthetic prion inoculum 10-fold resulted in no transmissions, this would imply <10 infectious units per undiluted inoculum and therefore that prions composed <1 in 10-8 of the material
    • -8 of the material.
  • 49
  • 52
    • 18744362997 scopus 로고    scopus 로고
    • E. A. Asante et al., EMBO J. 21, 6358 (2002).
    • (2002) EMBO J , vol.21 , pp. 6358
    • Asante, E.A.1
  • 60
    • 0033573778 scopus 로고    scopus 로고
    • A. F. Hill et al., Lancet 353, 183 (1999).
    • (1999) Lancet , vol.353 , pp. 183
    • Hill, A.F.1
  • 62
    • 0026600865 scopus 로고
    • H. Bueler et al., Nature 356, 577 (1992).
    • (1992) Nature , vol.356 , pp. 577
    • Bueler, H.1
  • 63
  • 64
    • 0027319326 scopus 로고
    • H. Bueler et al., Cell 73, 1339 (1993).
    • (1993) Cell , vol.73 , pp. 1339
    • Bueler, H.1
  • 66
    • 0027483615 scopus 로고
    • G. Forloni et al., Nature 362, 543 (1993).
    • (1993) Nature , vol.362 , pp. 543
    • Forloni, G.1
  • 68
    • 0029160006 scopus 로고
    • J. Collinge et al., Lancet 346, 569 (1995).
    • (1995) Lancet , vol.346 , pp. 569
    • Collinge, J.1
  • 69
  • 70
    • 0025681138 scopus 로고
    • K. K. Hsiao et al., Science 250, 1587 (1990).
    • (1990) Science , vol.250 , pp. 1587
    • Hsiao, K.K.1
  • 73
    • 0030054010 scopus 로고    scopus 로고
    • S. Brandner et al., Nature 379, 339 (1996).
    • (1996) Nature , vol.379 , pp. 339
    • Brandner, S.1
  • 74
    • 0242363656 scopus 로고    scopus 로고
    • G. Mallucci et al., Science 302, 871 (2003).
    • (2003) Science , vol.302 , pp. 871
    • Mallucci, G.1
  • 75
  • 76
    • 12144291519 scopus 로고    scopus 로고
    • L. Solforosi et al., Science 313, 1514 (2004).
    • (2004) Science , vol.313 , pp. 1514
    • Solforosi, L.1
  • 77
    • 0032488777 scopus 로고    scopus 로고
    • R. S. Hegde et al., Science 279, 827 (1998).
    • (1998) Science , vol.279 , pp. 827
    • Hegde, R.S.1
  • 79
    • 20344394154 scopus 로고    scopus 로고
    • B. Chesebro et al., Science 308, 1435 (2005).
    • (2005) Science , vol.308 , pp. 1435
    • Chesebro, B.1
  • 83
    • 0029863648 scopus 로고    scopus 로고
    • M. Fischer et al., EMBO J. 15, 1255 (1996).
    • (1996) EMBO J , vol.15 , pp. 1255
    • Fischer, M.1
  • 86
    • 84888721310 scopus 로고    scopus 로고
    • L remains hypothetical and cannot yet be assayed directly.
    • L remains hypothetical and cannot yet be assayed directly.
  • 87
    • 84888710999 scopus 로고    scopus 로고
    • We are grateful to J. Wadsworth for discussion and to R. Young for preparation of figures. J.C. is a director of, and both J.C. and A.R.C. are shareholders in, D-Gen Ltd, a research-based biomedical company that identifies, develops, and exploits proprietary diagnostic and therapeutic targets and technologies for prion-related diseases
    • We are grateful to J. Wadsworth for discussion and to R. Young for preparation of figures. J.C. is a director of, and both J.C. and A.R.C. are shareholders in, D-Gen Ltd., a research-based biomedical company that identifies, develops, and exploits proprietary diagnostic and therapeutic targets and technologies for prion-related diseases.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.